XDNY:F:F-Xtrackers MSCI Japan ESG Screened UCITS ETF 1D (EUR)

ETF | Others |

Last Closing

USD 15.32

Change

-0.02 (-0.10)%

Market Cap

USD 54.47B

Volume

1.75K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.28 (+1.02%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.46 (+0.90%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

+3.08 (+0.52%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.51 (+0.91%)

USD 91.82B
VUAA:F Vanguard S&P 500 UCITS Acc

+2.06 (+1.97%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+6.73 (+6.72%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

+0.06 (+0.74%)

USD 40.89B
0ZC:F Zscaler Inc

+6.16 (+3.41%)

USD 37.92B
BSND:F Danone SA

-0.10 (-0.78%)

USD 33.83B

ETFs Containing XDNY:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.92% 58% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.92% 58% F 62% D
Trailing 12 Months  
Capital Gain 14.31% 50% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.31% 50% F 57% F
Trailing 5 Years  
Capital Gain 15.57% 46% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.57% 46% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 5.48% 56% F 57% F
Dividend Return 5.48% 54% F 51% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.71% 58% F 85% B
Risk Adjusted Return 46.80% 56% F 66% D+
Market Capitalization 54.47B 99% N/A 96% N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike